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PHYSICAL EXERCISE ATTENUATES INFLAMMATION VIA
SUPPRESSION OF SYSTEMIC MACROPHAGE ACTIVATION
S. Agarwal, A. Blazek, N. Young, L-C. Wu, B. Lebelebicioglu, T. Hewett,
W. Jarjour, N. Weisleder. The Ohio State Univ., Columbus, OH, USA
Purpose: Earlier reports have shown that physiologic levels of exercise
(EX) suppress joint inﬂammation in OA in humans and in the exper-
imental models of OA. However, the mechanisms that explain such
effects of EX are little understood. Here we show that EX suppresses
local and systemic activation of macrophages to attenuate
inﬂammation.
Methods: All protocols were preapproved by the IACUC at The Ohio
State University. Transgenic BALBc female mice (12-14 wks old) con-
taining ﬁreﬂy luciferase cDNA in NF-kB response elements (NFkB-RE-
luc mice; Caliper Life Sciences, MA) were used as a tool to study tran-
scriptional regulation of the NF-kB gene, for examining the effects of
exercise (treadmill walking at 8M/min) on the cells involved in
inﬂammation. The inﬂammationwas triggered by injection of LPS (1 mg/
gm body weight) or IL-1b (50 ng/30 g body weight) in the right ankle of
the mice. Mice received following treatments, (i) no treatment (ii) EX
alone, (iii) LPS or IL-1beta injection alone, (iv) LPS or IL-1beta injections
and EX. The activation of NF-kB in the right ankle and systemic lymph
nodes was assessed 2 hrs, 24 hrs, 48 hrs or 5 days post induction of
inﬂammation by examining the luciferase activity by digital imaging
(IVIS 100) or by immunohistochemistry in vivo and in vitro. The
induction of proinﬂammatory cytokines in the serum and tissue sam-
ples was assessed by Multiplex ELISA assays (Biorad Labs). Statistical
analysis was performed by one-way ANOVAwith Tukey’s post hoc or T-
test.
Results: Control NFkB-RE-luc mice and those exposed to exercise
alone did not exhibit signiﬁcant NF-kB activation of F4/80þ macro-
phages. LPS injection in right ankle provoked a systemic and local
inﬂammatory response that was 6-8 fold greater within 2 hours of
LPS administration. Mice exposed to exercise following LPS injection
showed a signiﬁcant inhibition of LPS-induced NF-kB activation in
the macrophages. However, mice exposed to exercise following LPS
injection showed more than 90% suppression of NF-kB activation at
the site of LPS injection and in all lymph nodes. Further analysis of
NF-kB activation revealed that LPS activated NF-kB primarily in the
F4/80þ macrophages in axillary and inguinal lymph nodes, spleen
and mesentery, which was effectively suppressed by EX in all of
these lymph nodes and the site of injection. Immunoﬂuorescence
analysis for the presence of NF-kB in all of these tissue conﬁrmed
that exercise inhibited NF-kB nuclear translocation and its synthesis
in the F4/80þ macrophages.
To gain molecular insight into the signaling affected by inactivation of
NF-kB, we assessed the toll like receptor-4 (TLR-4) levels on the mac-
rophages and serum levels of cytokines that follow NF-kB activation.
Assessment of major pro-inﬂammatory cytokines IL-1b, TNF-a, IL-6, IL-
17, IL-12 and IL-8 all showed up-regulation by LPS, whereas EX effec-
tively suppressed pro-inﬂammatory cytokine induction. Similarly, he
expression of TLR-4 was suppressed by EX in LPS activated F4/80þ
macrophages.
The above ﬁndings prompted us to examine whether the anti-inﬂam-
matory effects of exercise are sustained. In these experiments mice
were either exercised every day or only for one day post LPS admin-
istration. The mice exposed to exercise every day suppressed NF-kB
activation in a sustained manner. However, effects of exercise were
transient in suppressing NF-kB activation and lasted only 24 h following
exercise.
Conclusions: The ﬁndings suggest that exercise is a systemic inhibitor
of inﬂammation and its actions are mediated via suppression of NF-kB
activity in the F4/80þ macrophages, the cells responsible for initiation
and perpetuation of inﬂammation. Furthermore, EX is a potent bio-
logical response modifying signal and potentially an indispensable tool
to regulate inﬂammation in OA and other joint diseases.539
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Taiwan; z Tzu-Chi Univ., Hualien, Taiwan; xAdvanced Inst. of
Manufacturing for High-tech Innovations and Dept. of Mechanical
Engineering, Natl. Chung Cheng Univ., Chiayi, Taiwan; kDept. of
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Purpose: Knee osteoarthritis (OA) is a prevailing health problem and its
etiology is still not deﬁned. Medial plica related medial abrasion syn-
drome (MAS) has long been declared to be a cause of knee disability. We
therefore conducted a series of prospective studies to verify the role of
MAS as a cause of knee OA. The outcomes of arthroscopic treatment for
this syndrome were also evaluated.
Methods: In a one-year duration, 571 knees of 367 patients having OA
and received arthroscopic treatment for MAS were enrolled into these
studies. Construction of three-dimensional dynamic ﬁnite element
model: An experimental study on the tensile strength of the medial
plica from 50 knees was conducted using high precision micro-force
tensile tests. The force-deﬂection curves resulting from these tests were
transferred to stress-strain curves to obtain the Young’s moduli of these
specimens. In another selected 30 knees with different size of medial
plica, the inner margins of the plicae were located by inserting needles
percutaneously under direct vision during arthroscopic examination.
The topographic changes of the margins of these plicae during knee
motion were recorded by ﬂuoroscopy and analyzed. Based on the
ﬁndings of these pilot studies, a three-dimensional dynamic ﬁnite
element model was constructed and used to investigate themagnitudes
of the cyclic pressures acting on the cartilage of the medial femoral
condyles by different types of medial plicae with various Young’s
moduli. Biochemical analysis: Interleukin-1b (IL-1b), matrix metal-
loprotease-3 (MMP-3) and MMP-3 mRNA expressions in the plica and
pannus-like tissue isolated from 24 knees were investigated by
immunohistochemistry, western blotting, reverse transcriptase poly-
merase chain reaction (PCR) and real-time PCR to clarify the impact of
medial plica on cartilage destruction. Surgical treatment of MAS:
Arthroscopic medial release (AMR) targeted on elimination of MAS and
regaining soft tissue balance around patello-femoral joint was devel-
oped to treat these knees. The Knee Society score (KSS) and the knee
injury and osteoarthritis outcome score (KOOS) were used for sub-
jective outcome study. The roentgenographic changes of femoral-tibial
angle (FTA) and joint space width (JSW) were evaluated for objective
outcomes.
Results: Three-dimensional dynamic ﬁnite elementmodel: The Young’s
modulus of the plica was found to be ranging from 10 to 110 MPa and
has positive correlation with patient’s age. All types of plicae remained
in contact with the medial femoral condyles and shifted medially when
the knees moved from extension to ﬂexion. The contact pressures were
positively correlated with the Young’s moduli of the medial plicae. The
maximum contact pressures of all simulation scenarios occurred when
the knees moved beyond 50 of ﬂexion. When the Young’s moduli of
medial plicae were set greater than 60 MPa, all types of plicae would
elicit contact pressures greater than 10 MPa on the medial femoral
condyles. Biochemical analysis: Immunohistochemistry showed that
MMP-3 was highly expressed in the plica and pannus-like tissue on the
femoral condyle. Western blotting of cultured supernatants showed
that interleukin-1b (IL-1b) treatment induced MMP-3 release by cells
isolated from pannus-like tissue or the plica. Reverse transcriptase PCR
and real-time PCR analysis showed that MMP-3 mRNA levels were
increased after IL-1b treatment of the cultured cells. MMP-3 and IL-1b
mRNAs were also found highly expressed in the plica and pannus-like
tissue. Surgical outcomes: There were 505 knees in 326 patients
available with more than 3 years follow-up and the mean follow-up
period was 38months (SD 3). Themean age of these patients at the time
of surgery was 60 (SD 10). All of the knees were found to have the
structure of pathologic medial plica. One hundred and thirty-four knees
Figure 1. (A) Equilibrium and (B) Dynamic modulus of cultured explants
over 6 weeks – All replicates of all donors combined
Figure 2. (A) GAG in explants and (B) GAG released in media
Figure 3. (A) MMP activity in media and (B) Collagen content in explants.
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examination, KSS and KOOS evaluation. Another 371 knees completed
the subjective outcome evaluation by telephone questionnaires. Of the
505 knees available for ﬁnal review the subjective assessment was
satisfactory in 432 (85.5%). For the 134 knees received in-depth out-
come studies, the Knee Society scores and all subscales of KOOS
improved statistically. The FTA improved from 1.57 (SD 3.9) to 1.93 (SD
4.1) (p¼0.03) and the JSW increased from 3.02 (SD 1.24) to 3.17 (SD 1.17)
(p¼0.01). The radiographic outcome revealed reversal of the degener-
ation process over the medial compartment in 82.1% of these knees
(N¼134).
Conclusion: Based on these translational investigations, we conclude
that MAS might be a cause of OA knee and can be effectively treated by
AMR.
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SPRIFERMIN (RHFGF18) PRESERVES ARTICULAR CARTILAGE
PROPERTIES DURING IN VITRO CULTURE
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Purpose: Current clinical practice of osteochondral allograft trans-
plantation requires time delay between tissue harvest and trans-
plantation for testing of bacterial and viral contamination. Allografts
are stored in cold conditions to preserve viability and tissue proper-
ties. Although not ideal, due to low chondrocyte survival, this proce-
dure is preferred to in vitro culture, as the latter results in rapid loss of
mechanical properties and GAG content. More generally, in vitro
culture of explants is used experimentally to study chondrocyte
response in their natural environment; however rapid turnover of
matrix makes results stemming from long-term cultures difﬁcult to
interpret. Several studies focused on developing in vitro culture sys-
tems to preserve allograft native properties, including a report of a
serum-free media formulation containing dexamethasone that pre-
served mechanical properties and biochemical content in juvenile
bovine explants for up to 8 weeks. Sprifermin (recombinant human
FGF18 (rhFGF18)) stimulates chondrocyte proliferation and matrix
production in vitro, reduces cartilage degeneration and increases de
novo matrix formation by osteoarthritic cartilage in vivo. In this study,
we evaluated the potential of Sprifermin to preserve explant proper-
ties in serum-containing media.
Methods: Full thickness cartilage explants (4mm diameter) were
harvested from trochlear grooves of juvenile bovine knees. After
overnight culture in complete medium, explants were trimmed to
similar thickness and cultured in complete medium with or
without rhFGF18 (Sprifermin, 100 ng/ml) applied for 24 hours
each week (1þ6 treatment). Over 6 weeks, explant mechanical
properties and molecular aspects were evaluated. Explants were
tested in unconﬁned compression to determine equilibrium (10%
strain, stress relaxation) and dynamic (1% strain, 1Hz) com-
pressive properties. For each explant, GAG content was deter-
mined using DMMB assay. Media was harvested at each media
change, and GAG release and MMP activity evaluated using DMMB
assay and SensoLyte 520 Generic MMP assay kit (Anaspec),
respectively.
Results: Mechanical integrity of cartilage explants cultured in vitro
decreases 1 week after isolation (EY¼1285 at Day0, 975 at Wk1), sta-
bilizing by week 2 at w 40% of original level (Fig 1A and 1B). This
phenomenon may relate in part to loss of proteoglycan from cut sur-
faces. When explants were cultured in serum-containing media with
Sprifermin, properties were preserved during week 1 of culture. After
week 1, treated and untreated explants decreased in properties, with
treated samples higher than untreated samples through week 3
(Untreated: EY¼563, G*¼7797 at Wk3; Treated: EY¼751, G*¼11287 at
Wk3).
By 4 weeks, no statistical differences were seen between treated and
untreated groups. At week 6, treated samples had lower EY but same G*
as untreated explantsThese differences could not solely be explained by GAG content (Fig 2A),
which showed continual decrease over time, with no statistical differ-
ences between treated and untreated explants until week 6, where
there was less GAG in treated explants (1.12% vs. 2.38%).At weeks 2 and 3, GAG release to the media was higher in treated
explants (Fig 2B), whereas MMP activity in treated explants was lower
(Fig 3A; Wk2: 0.87 mM vs. 0.10 mM; Wk3: 0.53 mM vs. 0.13 mM).MMP activity levels, collagen content of treated explants was higher
than untreated explants, with statistically signiﬁcant difference at week
3 (6.72% vs. 3.61% respectively), which could explain higher mechanical
properties of treated explants throughweek 3 (Fig 1A). This suppression
of MMP activity by rhFGF18 dissipated after week 4, both groups having
the same level of MMP activity.
Conclusions: Taken together, our results showed Sprifermin has an
inhibitory effect on MMP activity, which suppressed for 3 weeks deg-
radation of explant collagen. This study illustrates the potential of
Sprifermin to preserve cartilage explant mechanical properties over a
clinically relevant time course during which testing occurs before
allograft implantation. Hence current practice of storing allografts in
the cold could be replaced by maintenance of important cartilage
properties in the presence of rhFGF18 during the time period required
for safety screening.
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